comparemela.com

Latest Breaking News On - Zhou gaobo - Page 1 : comparemela.com

Four innovative drugs launched in three years, HKEX -Listed Simcere Pharmaceutical Group is on the Fast Track Toward Building an Innovation-Driven Global Pharmaceutical Company

/PRNewswire/ On Apr. 18, Simcere Pharmaceutical (2096.HK) disclosed the latest progress on the company s R&D and business operation on its first Investor.

Hong kongRen jinshengZhou gaoboSimcere pharmaceutical groupSimcere pharmaceuticalInvestor dayCentral nervous systemChief investment officerPharmaceutical groupSimcere pharmaceutical group limited

Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Market Approval of Trilaciclib Expected in China, Simcere Reveals Global Innovation Ambition on R&D Day

/PRNewswire/ On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held its first R&D day for.

United statesUnited kingdomEkevin oliverZhou gaoboAndrew zhuDanny chenBijoyesh mookerjeeSimcere pharmaceutical groupSimcere pharmaceuticalShanghai institute of materia medicaKey laboratoryChinese academy of sciencesExecutive vice presidentChief medical officerChief investment officerSenior vice president

Simcere: SIMCERE PHARMA (HK 2096) to host 2022 R&D Day

HONG KONG, April 7, 2022 /PRNewswire/ SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of "providing today's patients with medicines of the future"

Ekevin oliverRen jinshengJason baoDanny chenBijoyesh mookerjeeSimcere pharmaceutical groupInnovative drug developmentNational key laboratory of translational medicineZhou gaoboTang renhongPharmaceutical groupNational key laboratoryTranslational medicineInnovative drug

vimarsana © 2020. All Rights Reserved.